13th ProEducar Course for Fellow Interventionists at SOLACI-SBHCI 2023

SOLACI-SBHCI 2023 is round the corner and, as every year, we will be allocating a significant part of the event to the 13th ProEducar Course for Fellow Interventionists @SOLACI-SBHCI 2023, an intensive course of 1 day with the most relevant topics in interventional cardiology and with a practical approach. 

The course will be oriented to interventional cardiology fellows, featuring a state of the art scientific program and world class experts in the field. 

ProEducar SOLACI-SBHCI 2023

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

14th Edition of ProEducar Fellows Course Held at SOLACI-CACI 2024

With a new modality, the 14th edition of ProEducar Fellows Course was held during SOLACI-CACI 2024, which took place on August 7 thru 9...

SOLACI-CACI 2024 | ProEducar Call For Science: send your clinical case now

Since 2010, we have been conducting the Course for Fellows and Interventionists in Training by ProEducar-SOLACI continuously. In this edition of the SOLACI-CACI 2024 Congress, the...

See the Presentations of the 13th ProEducar Fellows Course

  During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.  Discover the presentations of the prestigious interventionists that made part of this 13th edition...

The best images of the 13th ProEducar Fellows Course at SOLACI-SBHCI 2023

Relive the best images of the 13th ProEducar Fellows Course held on August 2 during the SOLACI-SBHCI 2023 Congress in the URCA Room of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...